Approved Hyaluronate Inoshandiswa muViscosupplementation
Supartz, sarudzo ye sodium hyaluronate, ndeye ye hyaluronates inoshandiswa muevcosupplementation . Supartz inorohwa zvakananga mumabvi akabatanidza kudzorera kugadzirisa uye kugadzirisa zvinhu zve synovial fluid (kureva, joint joint). Iro sodium hyaluronate inoshandiswa muSupartz inobviswa kubva kumapundu ehuku. Sodium hyaluronate inonzi polysaccharide iyo inodzokorora disaccharide units of glucuronic acid uye N-acetylglucosamine .
Kubvumirwa kwaSupartz uye Supartz Fx
Supartz yakagamuchirwa neU.S. FDA musi waJanuary 24, 2001 pakurapwa kwemafupa osteoarthritis mumarwere akashaya kuwana rubatsiro rwakakwana nemishonga inoshandiswa, kusanganisira kurapa muviri, kurapa kwepanyama, mishonga inorwadza , kushandiswa kwekubatsira , uye kupisa kana kutonhora . Kushandisa mamwe majoini ari kuongororwa. Supartz yakashandiswa muJapan kubva muna 1987. Inoshandiswa kamwechete pavhiki kwemavhiki mashanu. Vamwe varwere vangave nemhinduro yakanaka mushure memavhiki matatu.
Musi waOctober 12, 2015, Bioventus, muumbi weSupartz, akazivisa kubudiswa kweSupartz Fx (10 mg sodium hyaluronate yakagadziriswa mu 1.0% yepanyama saline), iyo ine mazita akawedzerwa kubva kuSpartz yepakutanga, achibvumira kudzokorora majekiseni. Kunyange zvazvo kuchengetedzwa kwekuchengetedzwa kwakawedzerwa kwekudzokorora kwejaira, kubudirira kwekudzokorora kunenge kusati kwatangwa.
Manyevero uye Kuchengetedza
Supartz haifaniri kutarisirwa kune chero murwere nemunhu anozivikanwa hypersensitivity kune zvigadzirwa zve sodium hyaluronate.
Kuchenjerera kunofanira kushandiswa kana uchirapa varwere vane kuzivikanwa kweavianvian proteins, mazai, kana mapepa. Varwere vane utachiona kana chirwere cheganda munzvimbo iyo jekiseni raizopiwa harifaniri kutarisirwa naSupartz.
Kuchengetedzwa uye kubudirira kweSupartz hazvina kuiswa mumadzimai ane pamuviri, kana kuvakunda vakadzi.
Kushandiswa kwaro hakuna kumbobvunzwa muvana.
Nharaunda Dzakabatana
Zvose zvinokonzerwa nemigumisiro kana zviitiko zvakashata zvinosanganiswa naSupartz zvinosanganisira:
- Kurwadziwa pamwe chete kusina kuvhunika
- Kutambudzika shure
- Kwete-kurwadziwa kwakananga
- Injection site reaction
- Musoro
Kuvhuvhura kana kurwadziwa, izvo zvinopera, zvinogona kuitika mumubatanidzwa wakakonzerwa naSupartz. Varwere vanorayirwa kuti varege kuita zvinhu zvinotyisa kana kuti zvinorema mumaawa 48 achitevera injection.
The Bottom Line
Kuongororwa kwemakirini mashanu emakiriniki akagadzirirwa zvakanaka kwakaratidza kuti hapana kusiyana kwakakura pakati peSupartz nemapoka ekudzora maererano nezviitiko zvakashata. Kunyange zvazvo kuchengetedzwa kweSupartz nemamwe maeviscupplements kwakatsigirwa nekudzidza kwechiremba, kubudirira kwave kukwikwidzana. Nezvekubudirira, Cochrane Review yakagumisa kuti viscosupplementation inoshanda zvikuru kupfuura placebo, asi pane zvimwe zvidzidzo zvakakundikana pakuratidza kuti majekesheni anopa kuponeswa kwakanyanya.
Sources:
Supartz Fx. Kunyora Mashoko. Bioventus. http://www.supartzfx.com/wp-content/uploads/2015/07/SUPARTZ_FX_Package_Insert.pdf
Bioventus Inotanga Supartz Fx Iye Zvino ne Expanded Safety Label yekudzokorora Maitiro Akakuvara muKnee Osteoarthritis. Gumiguru 12, 2015.
http://www.bioventusglobal.com/news/press-releases/bioventus-launches-supartz-fx%E2%84%A2-now-expanded-safety-label-repeat-injection-cycles
Hyaluronic acid (Supartz): kudzokorora kushandiswa kwayo mu osteoarthritis yemabvi. Curan MP. Zvinodhaka nekukwegura. November 2010.
http://www.ncbi.nlm.nih.gov/pubmed/20964466